Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.90%
#2 Audiera Audiera +14.48%
#3 Ocean Protocol Ocean Protocol +7.13%
#4 The Bitcoin Bull The Bitcoin Bull +6.56%
#5 Rollbit Coin Rollbit Coin +6.44%
#6 Quack AI Quack AI +6.10%
#7 Wiki Cat Wiki Cat +4.88%
#8 HOME HOME +4.55%
#9 Tutorial Tutorial +4.09%
#10 RaveDAO RaveDAO +4.05%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Xếp hạng trong cổ phiếu #33981
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Giá cổ phiếu
$0.5762
Vốn hóa thị trường
$6.44M
Thay đổi (1 ngày)
-23.74%
Thay đổi (1 năm)
-56.68%
Quốc gia
US
Giao dịch Citius Pharmaceuticals, Inc. (CTXR)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Citius Pharmaceuticals, Inc. (CTXR)
Giá đóng cửa cao nhất: $0.69 vào 2026-08-01

Giá đóng cửa thấp nhất: $374.99 vào 2014-10-01
Lịch sử giá cổ phiếu của Citius Pharmaceuticals, Inc. từ 2014 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $110.31 -37.39%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 12.02%
BE